Chad R Brodt, MD
Cardiac Electrophysiology · East Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 4 carriers
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
16 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brodt’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A130241 · Current
Licensed to practise in California · since 2014 · expires 2027-09-30 · University of Sydney Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$472,269
Medicare paid this office $472,269 for 968 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 300 | $103,620 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 156 | $96,926 | $613 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 152 | $58,071 | $217 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 147 | $47,594 | $211 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $28,347 | $181 |
See all 31 services
| Long return visit (40+ min) | 300 | $103,620 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 156 | $96,926 | $613 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 152 | $58,071 | $217 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 147 | $47,594 | $211 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $28,347 | $181 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 36 | $18,226 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 465 | $9,062 | $12 |
| Programming of dual lead pacemaker system | 56 | $8,609 | $74 |
| Programming of heart rhythm stimulation after drug infusion | 166 | $8,151 | $48 |
| New patient visit (60+ min) | 36 | $7,450 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,938 | $104 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,041 | $403 |
| Long return visit (40+ min) | 43 | $5,852 | $125 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 76 | $4,400 | $22 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,013 | $138 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $3,976 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 19 | $3,440 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 183 | $3,125 | $15 |
| External shock to heart to regulate heart beat | 30 | $3,100 | $97 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,254 | $205 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 11 | $2,125 | $193 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 69 | $1,721 | $22 |
| Programming of cardiac rhythm monitor system | 14 | $1,470 | $59 |
| 3d radiographic procedure | 54 | $1,459 | $26 |
| Return visit (30+ min) | 13 | $1,227 | $94 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,071 | $32 |
| Return visit (30+ min) | 13 | $1,050 | $81 |
| Evaluation of cardiac rhythm monitor system | 15 | $961 | $46 |
| Heart rhythm recording of continous external ekg over 8-15 days | 68 | $959 | $12 |
| Insertion of heart rhythm monitor under skin | 13 | $807 | $62 |
| Heart muscle strain imaging | 16 | $695 | $39 |
Procedures Medicare counted
| Pacemaker insertion or repair | 32 | More than 80% of doctors who do this |
Who their Medicare patients are
968 Original Medicare patients in 2024. Average age 78 · Women 43% · Also on Medicaid 4% · Health risk score 1.25. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 64% · Coronary heart disease 39% · Heart failure 28% · Chronic kidney disease 24% · Diabetes 22% · Cancer 16% · Depression 12% · COPD 11% · Stroke 8% · Dementia 6%.
The office billed $2,276,476, Medicare allowed $612,907 and paid $472,269; for 4,148 services of 69 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 968 | 4,148 | 78 | 1.25 | $2,276,476 | $472,269 |
| 2023 | 915 | 3,957 | 78 | 1.23 | $2,093,935 | $463,224 |
| 2022 | 507 | 2,965 | 78 | 1.24 | $1,837,188 | $434,323 |
| 2021 | 364 | 2,327 | 76 | 1.36 | $1,158,504 | $298,025 |
| 2020 | 290 | 1,673 | 77 | 1.43 | $649,495 | $159,419 |
| 2019 | 1,167 | 2,679 | 75 | 2.12 | $1,107,100 | $217,901 |
| 2018 | 1,216 | 2,686 | 75 | 2.26 | $1,010,403 | $208,028 |
| 2017 | 963 | 2,170 | 75 | 1.96 | $897,684 | $185,003 |
| 2016 | 493 | 782 | 74 | 1.93 | $332,598 | $67,211 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 161 | $99,873 | $605 |
| Long return visit (40+ min) | 281 | $93,318 | $161 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 151 | $55,719 | $208 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 132 | $47,974 | $203 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 107 | $23,528 | $201 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 38 | $12,488 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $11,959 | $106 |
| Programming of heart rhythm stimulation after drug infusion | 163 | $9,892 | $59 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,816 | $446 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 410 | $8,678 | $14 |
| Programming of dual lead pacemaker system | 53 | $7,857 | $77 |
| New patient visit (60+ min) | 36 | $6,579 | $183 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 74 | $4,157 | $23 |
| External shock to heart to regulate heart beat | 34 | $3,961 | $99 |
| Return visit (30+ min) | 28 | $3,931 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $3,776 | $140 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 18 | $3,677 | $204 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 61 | $3,674 | $25 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $3,617 | $22 |
| Return visit (30+ min) | 27 | $2,576 | $89 |
| Programming of cardiac rhythm monitor system | 16 | $1,960 | $61 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 60 | $1,479 | $23 |
| Insertion of heart rhythm monitor under skin | 17 | $1,289 | $76 |
| 3d radiographic procedure | 44 | $1,216 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,038 | $32 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 41 | $963 | $22 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $814 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 60 | $802 | $12 |
| Heart muscle strain imaging | 15 | $625 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $473 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 41 | $400 | $9 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $352 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $218 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $184 | $10 |
2022: 32 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 156 | $103,891 | $653 |
| Long return visit (40+ min) | 247 | $83,586 | $164 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 131 | $49,935 | $200 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 133 | $48,991 | $203 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 39 | $16,371 | $420 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $12,609 | $91 |
| Programming of heart rhythm stimulation after drug infusion | 165 | $12,013 | $71 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $9,660 | $604 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,457 | $169 |
| New patient visit (60+ min) | 35 | $7,087 | $202 |
| Return visit (30+ min) | 52 | $6,719 | $116 |
| Programming of dual lead pacemaker system | 48 | $5,684 | $80 |
| External shock to heart to regulate heart beat | 45 | $4,567 | $95 |
| Return visit (30+ min) | 49 | $4,443 | $89 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 18 | $3,955 | $208 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 64 | $3,025 | $24 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 38 | $2,494 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $2,475 | $26 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 62 | $1,709 | $24 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,542 | $96 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 20 | $1,496 | $22 |
| Insertion of heart rhythm monitor under skin | 18 | $1,366 | $72 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 46 | $1,312 | $23 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,251 | $96 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 48 | $1,121 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 62 | $1,055 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $945 | $33 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 18 | $852 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 48 | $449 | $9 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $398 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $306 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 18 | $274 | $14 |
2021: 30 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 129 | $61,628 | $474 |
| Long return visit (40+ min) | 126 | $43,193 | $162 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 102 | $31,877 | $217 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 107 | $30,491 | $189 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 136 | $18,086 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $12,598 | $95 |
| Programming of heart rhythm stimulation after drug infusion | 129 | $8,458 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,642 | $182 |
| New patient visit (60+ min) | 38 | $7,298 | $192 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 127 | $7,015 | $55 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,997 | $466 |
| Return visit (30+ min) | 56 | $5,090 | $91 |
| Return visit (30+ min) | 27 | $3,691 | $119 |
| External shock to heart to regulate heart beat | 30 | $3,117 | $101 |
| Programming of dual lead pacemaker system | 18 | $2,410 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 35 | $2,119 | $25 |
| Long return visit (40+ min) | 15 | $2,009 | $134 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,688 | $24 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,640 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 25 | $1,471 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 42 | $1,143 | $23 |
| Short return visit (20+ min) | 16 | $983 | $61 |
| Insertion of heart rhythm monitor under skin | 12 | $930 | $78 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $789 | $72 |
| Heart rhythm recording of continous external ekg over 8-15 days | 41 | $723 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 25 | $570 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $365 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 25 | $238 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $225 | $11 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 20 | $130 | $6 |
2020: 30 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 132 | $37,952 | $279 |
| Long return visit (40+ min) | 75 | $17,668 | $137 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 64 | $11,049 | $136 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 100 | $9,606 | $91 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,532 | $449 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 59 | $7,635 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,078 | $96 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 128 | $4,691 | $36 |
| Programming of heart rhythm stimulation after drug infusion | 92 | $4,608 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,065 | $185 |
| Return visit (30+ min) | 54 | $3,918 | $73 |
| New patient visit (60+ min) | 18 | $3,511 | $195 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $3,180 | $289 |
| Return visit (30+ min) | 16 | $2,176 | $104 |
| External shock to heart to regulate heart beat | 13 | $1,752 | $103 |
| Programming of dual lead pacemaker system | 15 | $1,560 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $1,526 | $16 |
| Long return visit (40+ min) | 14 | $1,436 | $103 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,318 | $101 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,298 | $100 |
| Short return visit (20+ min) | 15 | $1,028 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 23 | $988 | $27 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 102 | $899 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $773 | $29 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $693 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 23 | $612 | $24 |
| Ultrasonic guidance for blood vessel access | 20 | $500 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 13 | $302 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $191 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 13 | $121 | $9 |
2019: 29 services
| Long return visit (40+ min) | 372 | $38,519 | $96 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 26 | $26,689 | $988 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 44 | $20,125 | $457 |
| Insertion of implantable defibrillator system | 13 | $10,704 | $823 |
| Programming of dual lead pacemaker system | 195 | $10,047 | $32 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 37 | $9,854 | $259 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $8,097 | $736 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 110 | $7,222 | $38 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,158 | $184 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $7,109 | $374 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 141 | $5,612 | $25 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 14 | $5,594 | $400 |
| Programming of multiple lead implantable defibrillator system | 63 | $5,369 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,969 | $94 |
| New patient visit (60+ min) | 33 | $4,732 | $143 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 29 | $4,138 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 464 | $3,815 | $7 |
| Programming of dual lead implantable defibrillator system | 43 | $2,847 | $48 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 100 | $2,776 | $24 |
| Programming of multiple lead pacemaker system | 30 | $1,837 | $38 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 38 | $1,718 | $22 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,190 | $99 |
| Insertion of heart rhythm monitor under skin | 17 | $1,152 | $68 |
| Programming of single lead implantable defibrillator system | 18 | $949 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 61 | $688 | $11 |
| Programming of single lead pacemaker system | 16 | $587 | $26 |
| Programming of cardiac rhythm monitor system | 16 | $365 | $23 |
| Evaluation of cardiac rhythm monitor system | 23 | $324 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $297 | $20 |
2018: 33 services
| Long return visit (40+ min) | 366 | $36,326 | $91 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 20 | $21,431 | $974 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 34 | $15,402 | $453 |
| Insertion of implantable defibrillator system | 18 | $14,585 | $810 |
| Programming of dual lead pacemaker system | 199 | $9,699 | $31 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 31 | $9,243 | $280 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $8,656 | $721 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 106 | $8,648 | $45 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 19 | $7,731 | $407 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 17 | $6,636 | $369 |
| New patient visit (60+ min) | 34 | $4,906 | $144 |
| Programming of multiple lead implantable defibrillator system | 69 | $4,831 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,992 | $121 |
| Removal and replacement of multiple lead defibrillator | 11 | $3,899 | $354 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 513 | $3,849 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 105 | $3,751 | $25 |
| Programming of dual lead implantable defibrillator system | 49 | $3,447 | $49 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $3,294 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,419 | $65 |
| Implantation patient-activated heart monitoring device | 12 | $2,214 | $185 |
| Programming of multiple lead pacemaker system | 27 | $2,213 | $36 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 83 | $2,143 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $1,819 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,404 | $94 |
| Programming of single lead implantable defibrillator system | 19 | $1,161 | $33 |
| Return visit (30+ min) | 16 | $989 | $62 |
| Programming of single lead pacemaker system | 14 | $741 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $574 | $11 |
| Short return visit (20+ min) | 12 | $553 | $46 |
| Programming of cardiac rhythm monitor system | 16 | $435 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $306 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 16 | $273 | $17 |
| Evaluation of cardiac rhythm monitor system | 18 | $268 | $14 |
2017: 30 services
| Long return visit (40+ min) | 261 | $27,281 | $97 |
| Insertion of implantable defibrillator system | 25 | $19,999 | $800 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $14,361 | $449 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 14 | $13,645 | $975 |
| Programming of dual lead pacemaker system | 185 | $9,094 | $33 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 19 | $7,728 | $407 |
| Return visit (30+ min) | 106 | $7,435 | $66 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 80 | $7,396 | $59 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $6,557 | $345 |
| Removal and replacement of multiple lead defibrillator | 15 | $5,395 | $360 |
| New patient visit (60+ min) | 34 | $4,955 | $146 |
| Programming of multiple lead implantable defibrillator system | 53 | $4,453 | $53 |
| Implantation patient-activated heart monitoring device | 23 | $4,107 | $179 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 92 | $3,619 | $29 |
| Programming of dual lead implantable defibrillator system | 54 | $3,468 | $50 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 117 | $2,815 | $23 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 18 | $2,375 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,319 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 231 | $2,209 | $7 |
| Programming of multiple lead pacemaker system | 26 | $1,810 | $41 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,615 | $90 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $1,423 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,231 | $65 |
| Programming of single lead implantable defibrillator system | 17 | $972 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 65 | $731 | $11 |
| Programming of single lead pacemaker system | 16 | $621 | $30 |
| Short return visit (20+ min) | 13 | $593 | $46 |
| Programming of cardiac rhythm monitor system | 16 | $451 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 25 | $447 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 13 | $305 | $23 |
2016: 15 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $7,005 | $467 |
| Long return visit (40+ min) | 62 | $6,243 | $99 |
| Return visit (30+ min) | 49 | $3,439 | $69 |
| New patient visit (60+ min) | 21 | $3,144 | $150 |
| Programming of dual lead pacemaker system | 58 | $2,473 | $34 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,163 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 239 | $2,042 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,694 | $60 |
| Programming of multiple lead implantable defibrillator system | 20 | $1,423 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,204 | $93 |
| Programming of dual lead implantable defibrillator system | 15 | $836 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $611 | $31 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $337 | $24 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 13 | $304 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $228 | $19 |
Medicaid work
$3,057 in 2019
Medicaid paid $3,057 for 290 billed services this clinician did in 2019, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 277 | $2,814 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 13 | $242 |
| 2019 | 290 | 2 | 78 | $3,057 |
| 2018 | 327 | 1 | 77 | $3,257 |
See the largest Medicaid services in earlier years
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 327 | $3,257 |
Drugs they prescribed that Part D paid
$423,437
Pharmacies billed $423,437 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,184) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
882 generic and 302 brand-name prescriptions · $423,437 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 159 | $216,403 | $1,361 |
| Xarelto | 45 | $53,194 | $1,182 |
| Jardiance | 31 | $47,879 | $1,544 |
| Dofetilide | 48 | $23,314 | $486 |
| Corlanor | 21 | $22,101 | $1,052 |
See all 26 drugs
| Eliquis | 159 | $216,403 | $1,361 |
| Xarelto | 45 | $53,194 | $1,182 |
| Jardiance | 31 | $47,879 | $1,544 |
| Dofetilide | 48 | $23,314 | $486 |
| Corlanor | 21 | $22,101 | $1,052 |
| Entresto | 14 | $18,134 | $1,295 |
| Diltiazem 24hr Er (Cd) | 43 | $2,044 | $48 |
| Flecainide Acetate | 46 | $1,866 | $41 |
| Irbesartan | 32 | $1,259 | $39 |
| Sotalol Af | 40 | $1,235 | $31 |
| Metoprolol | 81 | $1,106 | $14 |
| Carvedilol | 97 | $925 | $10 |
| Sotalol | 41 | $800 | $20 |
| Atorvastatin | 48 | $678 | $14 |
| Potassium Chloride | 24 | $627 | $26 |
| Rosuvastatin | 47 | $591 | $13 |
| Ezetimibe | 12 | $483 | $40 |
| Losartan | 33 | $297 | $9 |
| Pravastatin | 13 | $290 | $22 |
| Furosemide | 35 | $253 | $7 |
| Spironolactone | 23 | $191 | $8 |
| Lisinopril | 19 | $158 | $8 |
| Amlodipine Besylate | 24 | $145 | $6 |
| Metoprolol | 15 | $48 | $3 |
| Hydrochlorothiazide | 19 | $26 | $1 |
| Atenolol | 15 | $6 | $0 |
Year by year
| 2024 | 1,184 | 207 | 0% (0) | 26% | $423,437 |
| 2023 | 956 | 184 | 0% (0) | None | $332,861 |
| 2022 | 594 | 133 | 0% (0) | None | $163,636 |
| 2021 | 327 | 85 | 0% (0) | 32% | $101,257 |
| 2020 | 513 | 145 | None | 39% | $208,042 |
| 2019 | 1,146 | 227 | 0% (0) | 51% | $489,618 |
| 2018 | 1,423 | 247 | None | 46% | $409,894 |
| 2017 | 1,182 | 224 | None | 51% | $278,657 |
| 2016 | 249 | 93 | None | 39% | $41,033 |
| 2015 | 68 | None | None | 38% | $10,912 |
| 2014 | 56 | None | None | 30% | $2,515 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 120 | $171,366 | $1,428 |
| Xarelto | 51 | $61,135 | $1,199 |
| Dofetilide | 30 | $16,876 | $563 |
| Entresto | 11 | $16,701 | $1,518 |
| Corlanor | 13 | $16,312 | $1,255 |
| Flecainide Acetate | 38 | $2,488 | $65 |
| Metoprolol | 107 | $1,972 | $18 |
| Diltiazem 24hr Er (Cd) | 29 | $1,453 | $50 |
| Sotalol Af | 22 | $1,260 | $57 |
| Irbesartan | 26 | $1,035 | $40 |
| Sotalol | 41 | $968 | $24 |
| Carvedilol | 54 | $831 | $15 |
| Atorvastatin | 28 | $528 | $19 |
| Rosuvastatin | 29 | $499 | $17 |
| Potassium Chloride | 12 | $450 | $37 |
| Losartan | 26 | $353 | $14 |
| Spironolactone | 23 | $202 | $9 |
| Lisinopril | 25 | $200 | $8 |
| Metoprolol | 21 | $137 | $7 |
| Amlodipine Besylate | 27 | $127 | $5 |
| Furosemide | 23 | $105 | $5 |
| Hydrochlorothiazide | 20 | $79 | $4 |
2022: 18 drugs
| Eliquis | 62 | $80,994 | $1,306 |
| Xarelto | 25 | $24,365 | $975 |
| Multaq | 13 | $18,627 | $1,433 |
| Dofetilide | 26 | $14,596 | $561 |
| Metoprolol | 92 | $1,969 | $21 |
| Flecainide Acetate | 25 | $1,501 | $60 |
| Sotalol Af | 16 | $834 | $52 |
| Sotalol | 35 | $645 | $18 |
| Diltiazem 24hr Er (Cd) | 23 | $619 | $27 |
| Potassium Chloride | 15 | $345 | $23 |
| Irbesartan | 13 | $233 | $18 |
| Atorvastatin | 11 | $220 | $20 |
| Carvedilol | 20 | $207 | $10 |
| Warfarin | 12 | $181 | $15 |
| Furosemide | 24 | $92 | $4 |
| Spironolactone | 16 | $90 | $6 |
| Amlodipine Besylate | 17 | $56 | $3 |
| Hydrochlorothiazide | 22 | $49 | $2 |
2021: 9 drugs
| Eliquis | 37 | $39,000 | $1,054 |
| Xarelto | 35 | $35,845 | $1,024 |
| Multaq | 13 | $11,581 | $891 |
| Dofetilide | 12 | $4,261 | $355 |
| Metoprolol | 64 | $1,628 | $25 |
| Flecainide Acetate | 21 | $1,450 | $69 |
| Potassium Chloride | 13 | $322 | $25 |
| Carvedilol | 12 | $198 | $16 |
| Furosemide | 13 | $61 | $5 |
2020: 10 drugs
| Eliquis | 95 | $81,900 | $862 |
| Xarelto | 66 | $71,137 | $1,078 |
| Multaq | 16 | $20,858 | $1,304 |
| Dofetilide | 23 | $7,711 | $335 |
| Flecainide Acetate | 43 | $4,580 | $107 |
| Metoprolol | 65 | $2,334 | $36 |
| Diltiazem 24hr Er (Cd) | 16 | $686 | $43 |
| Sotalol | 18 | $608 | $34 |
| Carvedilol | 24 | $558 | $23 |
| Metoprolol | 21 | $101 | $5 |
2019: 17 drugs
| Eliquis | 252 | $186,756 | $741 |
| Xarelto | 169 | $147,254 | $871 |
| Multaq | 56 | $63,750 | $1,138 |
| Dofetilide | 52 | $22,677 | $436 |
| Pradaxa | 39 | $22,459 | $576 |
| Tikosyn | 18 | $14,343 | $797 |
| Savaysa | 17 | $6,176 | $363 |
| Flecainide Acetate | 58 | $5,474 | $94 |
| Metoprolol | 125 | $3,569 | $29 |
| Amiodarone | 48 | $2,441 | $51 |
| Carvedilol | 40 | $849 | $21 |
| Sotalol | 34 | $814 | $24 |
| Diltiazem 24hr Er (Cd) | 24 | $770 | $32 |
| Digoxin | 16 | $682 | $43 |
| Losartan | 12 | $243 | $20 |
| Metoprolol | 42 | $222 | $5 |
| Pantoprazole | 24 | $195 | $8 |
2018: 25 drugs
| Eliquis | 273 | $145,205 | $532 |
| Xarelto | 212 | $135,536 | $639 |
| Multaq | 39 | $30,723 | $788 |
| Dofetilide | 55 | $27,089 | $493 |
| Pradaxa | 40 | $24,016 | $600 |
| Tikosyn | 15 | $9,497 | $633 |
| Savaysa | 21 | $7,414 | $353 |
| Flecainide Acetate | 81 | $5,129 | $63 |
| Metoprolol | 178 | $4,456 | $25 |
| Amiodarone | 71 | $3,036 | $43 |
| Enoxaparin | 27 | $2,385 | $88 |
| Propafenone | 19 | $1,547 | $81 |
| Digoxin | 23 | $1,066 | $46 |
| Sotalol | 30 | $778 | $26 |
| Carvedilol | 59 | $665 | $11 |
| Diltiazem 24hr Er (Cd) | 25 | $567 | $23 |
| Acebutolol | 17 | $505 | $30 |
| Metoprolol | 65 | $433 | $7 |
| Diltiazem 24hr Er | 11 | $339 | $31 |
| Cartia Xt | 20 | $303 | $15 |
| Diltiazem | 11 | $248 | $23 |
| Losartan | 13 | $153 | $12 |
| Atenolol | 17 | $123 | $7 |
| Pantoprazole | 12 | $77 | $6 |
| Cephalexin | 14 | $64 | $5 |
2017: 19 drugs
| Xarelto | 180 | $92,696 | $515 |
| Eliquis | 196 | $83,102 | $424 |
| Multaq | 38 | $26,753 | $704 |
| Dofetilide | 52 | $26,460 | $509 |
| Pradaxa | 28 | $15,619 | $558 |
| Savaysa | 19 | $6,202 | $326 |
| Metoprolol | 185 | $4,544 | $25 |
| Flecainide Acetate | 62 | $2,951 | $48 |
| Enoxaparin | 26 | $2,102 | $81 |
| Amiodarone | 49 | $1,407 | $29 |
| Diltiazem 24hr Er | 18 | $650 | $36 |
| Digoxin | 17 | $564 | $33 |
| Carvedilol | 67 | $520 | $8 |
| Metoprolol | 53 | $258 | $5 |
| Cartia Xt | 14 | $211 | $15 |
| Atenolol | 23 | $155 | $7 |
| Pantoprazole | 12 | $84 | $7 |
| Cephalexin | 12 | $70 | $6 |
| Lisinopril | 13 | $55 | $4 |
2016: 7 drugs
| Eliquis | 36 | $15,540 | $432 |
| Xarelto | 31 | $14,088 | $454 |
| Metoprolol | 26 | $594 | $23 |
| Flecainide Acetate | 17 | $452 | $27 |
| Amiodarone | 15 | $131 | $9 |
| Cephalexin | 23 | $129 | $6 |
| Carvedilol | 11 | $84 | $8 |
2015: 2 drugs
| Ranexa | 12 | $5,479 | $457 |
| Fenofibrate | 12 | $1,039 | $87 |
Money from drug and device companies
$38,204 in 2025
| 2025 | 9 | 89 | $29,175 | $38,204 |
| 2024 | 10 | 106 | $63,150 | $73,305 |
| 2023 | 9 | 83 | $56,250 | $64,555 |
| 2022 | 8 | 60 | $2,338 | $16,650 |
| 2021 | 5 | 36 | $625 | $14,069 |
| 2020 | 3 | 41 | $25,340 | $28,574 |
| 2019 | 5 | 59 | $29,300 | $33,896 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $28,508 | 37 payments
|
| Boston Scientific | Farapulse | $6,023 | 20 payments
|
| Biosense Webster | Carto 3 | $2,261 | 10 payments
|
| Abbott Laboratories | Perclose Prostyle | $610 | 12 payments
|
| Siemens Medical Solutions USA | Acuson Origin Diagnostic Ultrasound System | $288 | 1 payment
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $210 | 3 payments
|
See all 89 published payments
| AtriCure | Consulting · 2025-12-19 | Epi-Sense Guided Coagulation System With Visitrax | $2,500 |
| Boston Scientific | Meals · 2025-12-11 | Farapulse | $35 |
| AtriCure | Meals · 2025-12-11 | Synergy Ablation System | $22 |
| Abbott Laboratories | Meals · 2025-11-26 | Perclose Prostyle | $99 |
| Abiomed | Meals · 2025-11-22 | None | $85 |
| AtriCure | Consulting · 2025-11-21 | None | $15,000 |
| AtriCure | Consulting · 2025-11-14 | Epi-Sense Guided Coagulation System With Visitrax | $1,250 |
| AtriCure | Meals · 2025-11-13 | Synergy Ablation System | $17 |
| Biosense Webster | Meals · 2025-11-11 | Carto 3 | $112 |
| AtriCure | Consulting · 2025-11-07 | Epi-Sense Guided Coagulation System With Visitrax | $2,500 |
| Boston Scientific | Paid to speak or teach · 2025-11-06 | Farapulse | $2,500 |
| Boston Scientific | Paid to speak or teach · 2025-11-06 | Farapulse | $625 |
| AtriCure | Consulting · 2025-10-31 | Synergy Ablation System | $1,250 |
| Biosense Webster | Meals · 2025-10-28 | Soundstar | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-10-27 | Lifevest | $39 |
| AtriCure | Consulting · 2025-10-17 | Epi-Sense Guided Coagulation System With Visitrax | $1,250 |
| AtriCure | Travel · 2025-10-07 | Epi-Sense Guided Coagulation System With Visitrax | $371 |
| AtriCure | Meals · 2025-10-07 | Synergy Ablation System | $39 |
| AtriCure | Meals · 2025-10-06 | Synergy Ablation System | $100 |
| AtriCure | Travel · 2025-10-06 | Epi-Sense Guided Coagulation System With Visitrax | $100 |
| AtriCure | Meals · 2025-10-06 | Synergy Ablation System | $41 |
| Boston Scientific | Meals · 2025-10-04 | Farapulse | $455 |
| Boston Scientific | Meals · 2025-10-03 | Farapulse | $175 |
| Boston Scientific | Meals · 2025-10-03 | Farapulse | $550 |
| Boston Scientific | Travel · 2025-10-03 | Farapulse | $380 |
| Boston Scientific | Travel · 2025-10-03 | Farapulse | $88 |
| Boston Scientific | Meals · 2025-10-02 | Farapulse | $10 |
| Boston Scientific | Travel · 2025-10-02 | Farapulse | $380 |
| Boston Scientific | Travel · 2025-10-02 | Farapulse | $396 |
| Boston Scientific | Meals · 2025-09-25 | Farapulse | $35 |
| Boston Scientific | Meals · 2025-09-23 | Farapulse | $35 |
| AtriCure | Travel · 2025-09-18 | Epi-Sense Guided Coagulation System With Visitrax | $30 |
| AtriCure | Travel · 2025-09-18 | Epi-Sense Guided Coagulation System With Visitrax | $1,894 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| Boston Scientific | Meals · 2025-09-16 | Farapulse | $31 |
| Boston Scientific | Meals · 2025-09-16 | Farapulse | $42 |
| Boston Scientific | Meals · 2025-09-15 | Farapulse | $33 |
| Boston Scientific | Meals · 2025-09-15 | Farapulse | $19 |
| AtriCure | Meals · 2025-09-02 | Epi-Sense Guided Coagulation System With Visitrax | $33 |
| AtriCure | Meals · 2025-08-18 | Epi-Sense Guided Coagulation System With Visitrax | $25 |
| AtriCure | Meals · 2025-08-18 | Atriclip Laa Exclusion System | $27 |
| Biosense Webster | Meals · 2025-08-13 | Nuvision Ice Catheter | $26 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $144 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-07-17 | Epi-Sense Guided Coagulation System With Visitrax | $37 |
| Abbott Laboratories | Meals · 2025-07-11 | Perclose Prostyle | $31 |
| Abbott Laboratories | Meals · 2025-06-27 | Agilis | $25 |
| AtriCure | Meals · 2025-06-26 | Epi-Sense Guided Coagulation System With Visitrax | $29 |
| Biotronik | Meals · 2025-06-12 | Amvia Edge | $102 |
| AtriCure | Meals · 2025-06-09 | Epi-Sense Guided Coagulation System With Visitrax | $27 |
| Biosense Webster | Meals · 2025-05-30 | Carto 3 | $5 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-29 | Lifevest | $22 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $36 |
| AtriCure | Meals · 2025-05-19 | Synergy Ablation System | $11 |
| Medtronic | Meals · 2025-05-14 | Aurora Ev-Icd Mri Surescan | $25 |
| Biosense Webster | Consulting · 2025-05-13 | Carto 3 | $1,800 |
| Siemens Medical Solutions USA | Meals · 2025-05-12 | Acuson Origin Diagnostic Ultrasound System | $288 |
| AtriCure | Meals · 2025-05-07 | Epi-Sense Guided Coagulation System With Visitrax | $27 |
| Abbott Laboratories | Meals · 2025-05-01 | Agilis | $24 |
| AtriCure | Meals · 2025-04-25 | Synergy Ablation System | $58 |
| Biotronik | Meals · 2025-04-25 | Acticor 7 Vr-T Dx | $36 |
| AtriCure | Meals · 2025-04-24 | Epi-Sense Guided Coagulation System With Visitrax | $148 |
| Biotronik | Meals · 2025-04-24 | Acticor 7 Vr-T Dx | $21 |
| Boston Scientific | Meals · 2025-04-23 | Farapulse | $47 |
| Abbott Laboratories | Meals · 2025-04-23 | Perclose Prostyle | $15 |
| Abbott Laboratories | Meals · 2025-04-18 | Perclose Proglide | $101 |
| Boston Scientific | Meals · 2025-04-16 | Farapulse | $137 |
| AtriCure | Meals · 2025-04-14 | Synergy Ablation System | $142 |
| AtriCure | Meals · 2025-04-10 | Synergy Ablation System | $103 |
| AtriCure | Meals · 2025-04-10 | Synergy Ablation System | $23 |
| Biosense Webster | Meals · 2025-04-05 | Nuvision Ice Catheter | $26 |
| Biosense Webster | Meals · 2025-03-29 | Carto 3 | $4 |
| Biosense Webster | Meals · 2025-03-27 | Carto 3 | $32 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Abbott Laboratories | Meals · 2025-03-17 | Ensite | $214 |
| Boston Scientific | Meals · 2025-03-12 | Watchman Flx | $51 |
| Abbott Laboratories | Meals · 2025-03-11 | Perclose Prostyle | $24 |
| Biosense Webster | Meals · 2025-03-07 | Carto 3 | $83 |
| Medtronic | Meals · 2025-03-07 | Micra | $22 |
| AtriCure | Meals · 2025-02-26 | Synergy Ablation System | $30 |
| Abbott Laboratories | Meals · 2025-02-13 | Perclose Prostyle | $16 |
| Abbott Laboratories | Meals · 2025-01-21 | Perclose Prostyle | $29 |
| AtriCure | Meals · 2025-01-16 | Synergy Ablation System | $270 |
| AtriCure | Meals · 2025-01-15 | Epi-Sense Guided Coagulation System With Visitrax | $26 |
| Abbott Laboratories | Meals · 2025-01-13 | Perclose Prostyle | $23 |
| Abbott Laboratories | Meals · 2025-01-13 | Perclose Prostyle | $9 |
| AtriCure | Consulting · 2025-01-10 | Isolator Surgical Ablation System | $500 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $73,305
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $50,366 | 33 payments
|
| Medical Device Business Services | Carto 3 | $11,925 | 6 payments
|
| Boston Scientific | Rhythmia Mapping System | $8,063 | 18 payments
|
| Biosense Webster | Carto 3 | $1,070 | 19 payments
|
| Impulse Dynamics (USA) | Optimizer | $776 | 5 payments
|
| Abbott Laboratories | Perclose Prostyle | $345 | 16 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $302 | 4 payments
|
| Kestra Medical Technology Services | Assure Wcd | $215 | 3 payments
|
| Siemens Medical Solutions USA | None | $146 | 1 payment
|
| Cortex | None | $96 | 1 payment
|
2023: $64,555
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $49,587 | 46 payments
|
| Medical Device Business Services | Carto 3 | $13,050 | 6 payments
|
| Biosense Webster | Carto 3 | $614 | 15 payments
|
| Abbott Laboratories | Ensite | $458 | 7 payments
|
| Impulse Dynamics (USA) | Optimizer | $364 | 3 payments
|
| Ablacon | None | $241 | 1 payment
|
| Medtronic | Micra | $140 | 3 payments
|
| Kestra Medical Technology Services | Assure Wcd | $87 | 1 payment
|
| Biotronik | Edora 8 Dr-T | $13 | 1 payment
|
2022: $16,650
| Biotronik | Acticor 7 Vr-T Dx | $8,878 | 8 payments
|
| AtriCure | Synergy Ablation System | $5,875 | 34 payments
|
| Impulse Dynamics (USA) | Optimizer | $634 | 5 payments
|
| Abbott Laboratories | Ensite Precision | $450 | 5 payments
|
| Biosense Webster | Carto 3 | $447 | 2 payments
|
| Boston Scientific | Rhythmia Mapping System | $153 | 2 payments
|
| Medtronic | Cobalt Dr Mri Surescan | $151 | 2 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $64 | 2 payments
|
2021: $14,069
| Atricure | Synergy Ablation System | $12,783 | 29 payments
|
| Biotronik | Acticor | $903 | 3 payments
|
| Biosense Webster | Carto 3 | $198 | 2 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $170 | 1 payment
|
| Medtronic | Reveal Linq | $15 | 1 payment
|
2020: $28,574
| Atricure | Atricure Synergy Ablation System | $27,813 | 32 payments
|
| Medtronic Vascular | Claria Mri | $723 | 8 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $38 | 1 payment
|
2019: $33,896
| AtriCure | Atricure Synergy Ablation System | $32,096 | 41 payments
|
| CardioFocus | None | $1,122 | 3 payments
|
| Abbott Laboratories | Confirm Rx | $352 | 7 payments
|
| Medtronic Vascular | Azure | $191 | 4 payments
|
| Biotronik | None | $134 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Cortex, Inc. · Resolve-Af · 2024 | Their institution | $131,654 |
| Impulse Dynamics (USA) Inc. · Assessment of Ccm in Hf With Higher Ejection Fraction (Aim Higher) · 2024 | Their institution | $39,420 |
| Boston Scientific Corporation · Resolve Af · 2025 | Their institution | $37,053 |
| AtriCure, Inc. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2025 | Their institution | $28,070 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial and Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2019 | Their institution | $23,468 |
| ATRICURE, INC. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2023 | Their institution | $21,750 |
| Impulse Dynamics (USA) Inc. · Assessment of Ccm in Hf With Higher Ejection Fraction (Aim Higher) · 2025 | Their institution | $12,316 |
| Medical Device Business Services, Inc. · Prospective Review of the Safety and Effectiveness of the Thermocool Smarttouch Sf Catheter Evaluated for Treating Symptomatic Persistent Af (Precept) · 2020 | Their institution | $11,813 |
| AtriCure, Inc. · Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2020 | Their institution | $10,511 |
| ATRICURE, INC. · Pivotal Study of A Dual Epicardial & Endocardial Procedure (Deep) Approach for Treatment of Subjects With Persistent Or Long Standing Persistent Atrial Fibrillation With Radiofrequency Ablation · 2020 | Their institution | $10,511 |
| Boston Scientific Corporation · Preempt Hf · 2019 | Their institution | $4,500 |
| AtriCure, Inc. · Inappropriate Sinus Tachycardiaregistry · 2025 | Their institution | $2,886 |
| Impulse Dynamics (USA) Inc. · Assessment of Ccm in Hf With Higher Ejection Fraction (Aim Higher) · 2023 | Their institution | $2,000 |
| Medical Device Business Services, Inc. · Prospective Review of the Safety and Effectiveness of the Thermocool Smarttouch Sf Catheter Evaluated for Treating Symptomatic Persistent Af (Precept) · 2019 | Their institution | $1,701 |
| Medtronic Vascular, Inc. · Wrap-It · 2019 | Their institution | $950 |
| Janssen Research & Development, LLC · Smartadhere - Smartphones To Improve Rivaroxaban Adherence in Atrial Fibrillation · 2019 | Their institution | $640 |
Professional record
- NPI
- 1164696035
- Licence
- CA A130241California A130241: Current · expires 2027-09-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-04-22
- NPI last updated
- 2019-12-30
- NPI record certified
- 2019-12-30
This is when the NPI record was last certified, not a medical board exam.